• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Fred Pennic, Editor-in Chief | HIT Consultant

Fred Pennic is the Founder and Editor-in-Chief of HIT Consultant.

Microsoft, Adaptive, Providence Partner to Decode COVID-19 Immune Response

by Fred Pennic 03/20/2020 Leave a Comment

To generate immune response data, Adaptive will open enrollment in April to collect de-identified blood samples, using a LabCorp-enabled mobile phlebotomy service, from individuals diagnosed with or recovered from COVID-19 in a virtual clinical trial managed by Covance. Immune cell receptors from these blood samples will be sequenced using Illumina platform technology and mapped to SARS-CoV-2-specific antigens that will have been confirmed by Adaptive’s proprietary immune medicine platform to induce an immune response. The immune response signature found from the initial discovery work and the initial set of samples will be uploaded to the open data access portal. Leveraging Microsoft’s hyperscale machine learning capabilities and the Azure cloud platform, the accuracy of the immune response signature will be continuously improved and updated online in real time as more trial samples are sequenced from the study. Providence to Serve as Clinical Collaborator To expedite the development and relevance of the immune response signature across the global population, the companies are seeking additional participation from institutions and research groups around the world to contribute blood samples to this open data initiative. Providence, a large health system with 51 hospitals, including the one near Seattle that treated the first U.S. COVID-19 patient, is an initial clinical collaborator. “The solution to COVID-19 is not likely going to come from one person, one company or one country. This is a global issue, and it will be a global effort to solve it,” said Peter Lee, corporate vice president, AI and Research, Microsoft. “Making critical information about the immune response accessible to the broader research community will help advance ongoing and new efforts to solve this global public health crisis, and we can accomplish this goal through our proven TCR-Antigen mapping partnership with Adaptive.” Timing & Enrollment Timing and enrollment details about the upcoming study and the open data access portal will be coming soon. Institutions or collaborators interested in contributing blood samples can direct inquiries to COVID19ImmuneResponse@adaptivebiotech.com.

What You Should Know: - Microsoft and Adaptive Biotechnologies have expanded their partnership to map the human immune response to COVID-19 and advance our understanding of the disease. - Data from this study will be made available through an open-access portal to help researchers, public health organizations and industry improve diagnostics, help triage patients based on the immune response to the disease, and inform vaccine discovery for COVID-19. - Other industry leaders including
Read More

Scanwell Health Launches Clinical-Grade Rapid At-Home COVID-19 Test Kits

by Fred Pennic 03/20/2020 Leave a Comment

Scanwell Health Launches Clinical-Grade Rapid At-Home COVID-19 Test Kits

What You Should Know: - Scanwell Health announced the first clinical-grade rapid at-home test for COVID-19. - Scanwell secures exclusive rights to license China FDA-cleared rapid serology test from INNOVITA; Partners with nationwide telehealth provider Lemonaid Health to distribute smartphone-enabled tests to individuals in the U.S. - After a quick screening, eligible patients are sent a kit via next-business-day delivery. Patients take the test at home and
Read More

AWS Launches $20M Initiative to Accelerate COVID-19 Diagnostics, Research, and Testing

by Fred Pennic 03/20/2020 Leave a Comment

AWS Launches $20M Initiative to Accelerate COVID-19 Diagnostics, Research, and Testing

What You Should Know: - Amazon Web Services (AWS) announced its commitment of $20 million and the launch of the Diagnostic Development Initiative to support customers who are working to bring better, more accurate, diagnostics solutions to market faster and promote better collaboration across organizations.  - With the assistance of AWS, customers can accelerate diagnostic research, innovation, and development to speed our collective understanding and detection of COVID-19 and other
Read More

Business General Liability Insurance: Choosing the Right Provider

by Fred Pennic 03/20/2020 Leave a Comment

Business General Liability Insurance: Choosing the Right Provider

One of the best ways to protect your company from being blindsided by issues related to court would be to purchase general liability insurance for your business. There have been too many situations where an unfortunate business owner lost everything they worked for due to someone finding a hole in their legal security and taking advantage of the situation. To help protect your company from the worst, the best thing to do would be to make use of business general liability insurance as soon as
Read More

At-Home COVID-19 Test Kits Will Be Available to U.S. Consumers for $139 on March 23rd

by Fred Pennic 03/19/2020 Leave a Comment

FDA Approves Everlywell’s At-Home COVID-19 Nasal Swab Test Kits

What You Should Know: - Everlywell announces that an at-home collection kit with telehealth diagnosis for COVID-19 will be available to consumers starting Monday, March 23 for $139. - The initial offering of 30,000 collection kits will significantly impact total coronavirus testing capacity in the United States; free telehealth consults are included for those with positive results. - By working with multiple labs to scale infrastructure, the company plans to have testing and diagnosis
Read More

COVID-19: Glooko Offers Free Remote Care to Medical Clinics and People with Diabetes

by Fred Pennic 03/19/2020 Leave a Comment

COVID-19 Pandemic: Glooko Offers Free Remote Care to Medical Clinics & Patients with Diabetes

What You Should Know: - Glooko today announced that during the COVID-19 pandemic they are taking action to serve the global diabetes community by providing a no-charge remote care solution that provides live patient-to-clinician connectivity. - To minimize the risk to people with diabetes during this time by broadening access to a remote medical appointment with healthcare providers, Glooko is offering its secure, privacy-protected remote care solution at no charge to medical clinics and
Read More

COVID-19: MEDITECH Offers Expanse Ambulatory Expanse Customers It’s Scheduled Virtual Visits Functionality Free of Charge

by Fred Pennic 03/18/2020 Leave a Comment

COVID-19: MEDITECH Offers Expanse Ambulatory Expanse Customers Its Scheduled Virtual Visits Functionality Free of Charge

What You Should Know: MEDITECH offers Expanse Ambulatory and Patient Portal users complimentary deployment of our Scheduled Virtual Visits functionality for a six-month period. This solution, deployed through MEDITECH’s rapid response team, can assist customers in battling the spread of the COVID-19, reducing unnecessary risk to others and identifying the patients in need of care. In an effort to help combat the COVID-19 pandemic, MEDITECH announced it will offer all customers
Read More

CommonSpirit Health Suspends Patient Billing for COVID-19 Testing & Treatment

by Fred Pennic 03/18/2020 Leave a Comment

Gates Foundation, Wellcome, Mastercard Launch COVID-19 Therapeutics Accelerator

What You Need to Know: - CommonSpirit Health suspends all patient billing for testing and treatment for COVID-19 across 21 states. - "The last thing our patients should worry about if they experience symptoms characteristic of this coronavirus is the cost of seeking care," said Lloyd H. Dean, CEO of CommonSpirit Health. CommonSpirit Health, a nonprofit, Catholic health system announced it will suspend sending patient bills related to the testing and treatment of
Read More

New App Prevents Exposure to Coronavirus in Medical Waiting Rooms

by Fred Pennic 03/17/2020 Leave a Comment

New App Prevents Exposure to Coronavirus in Medical Waiting Rooms

What You Need to Know: - A new app called DocClocker has unveiled a way for patients to prevent exposure to potential coronavirus carriers in medical waiting rooms. - With the DocClocker app, which was created and funded entirely by practicing medical physicians, patients can receive real-time wait times; preventing the spread of the highly contagious virus by limiting the exposure of sick patients in waiting rooms. DocClocker®, a pioneering app that enables patients for the first
Read More

IntelyCare Launches Free COVID-19 Training for Nurses

by Fred Pennic 03/17/2020 Leave a Comment

IntelyCare Launches Free COVID-19 Training for Nurses

What You Need to Know: - Nurse staffing technology provider IntelyCare is launching free COVID-19 training certification for nursing professionals. - The free, web-based version of the training to all nurses in the U.S., and requiring its nursing employees to complete the COVID-19 Best Practices Course in the IntelyCare app before taking shifts. In response to the global COVID-19 pandemic, IntelyCare, a leading intelligent workforce management solution for post-acute
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 348
  • Go to page 349
  • Go to page 350
  • Go to page 351
  • Go to page 352
  • Interim pages omitted …
  • Go to page 450
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |